Financhill
Back

Pharmaron Beijing Quote, Financials, Valuation and Earnings

Sell
1

PHBBF
Pharmaron Beijing

Last Price:
1.93
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Pharmaron Beijing Price Quote

$1.93

Pharmaron Beijing Key Stats

Sell
1
Pharmaron Beijing (PHBBF) is a Sell

Day range:
$1.93 - $1.93
52-week range:
$1.93 - $2.25
Dividend yield:
2.18%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
0
Avg. volume:
3
1-year change:
0%
Market cap:
$2.5B
Revenue:
$1.5B
EPS:
$0.18

How Much Does Pharmaron Beijing Make?

Is Pharmaron Beijing Growing As A Company?

  • What Is Pharmaron Beijing's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.2%
  • What Is Pharmaron Beijing's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.31%

Pharmaron Beijing Stock Price Performance

What Is Pharmaron Beijing 52-Week High & Low?

Pharmaron Beijing Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pharmaron Beijing?

  • How Much Debt Does Pharmaron Beijing Have?
    Total long term debt quarterly is $789.6M
  • How Much Cash Does Pharmaron Beijing Have?
    Cash and short term investments quarterly total is $370M
  • What Is Pharmaron Beijing’s Book Value Per Share?
    Book value per share is 1.24

Is Pharmaron Beijing Cash Flow Positive?

Data Unavailable

Pharmaron Beijing Return On Invested Capital

  • Is Management Doing A Good Job?
    PHBBF return on invested capital is 9.23%
  • What Is Pharmaron Beijing Return On Assets?
    ROA measures how assets are converting to revenues and is 7.37%
  • What Is PHBBF Return On Equity?
    ROE is a measure of profitability and is 13.94%

Pharmaron Beijing Earnings Date & Stock Price

Pharmaron Beijing Competitors

  • Who Are Pharmaron Beijing's Competitors?
    Below is a list of companies who compete with Pharmaron Beijing or are related in some way:
    • Global Pharmatech Inc (GBLP)
    • HUTCHMED (China) Ltd (HCM)
    • Prenetics Global Ltd (PRE)
    • Regencell Bioscience Holdings Ltd (RGC)
    • Sino Biopharmaceutical Ltd (SBHMY)

Pharmaron Beijing Dividend Yield

Pharmaron Beijing Analyst Estimates

YoY Growth Past Surprise
EPS: 30.57% 0%
Revenue: 20.3% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many PHBBF shares are owned by institutional investors?
    80M PHBBF shares are owned by institutional investors
  • How many PHBBF shares are owned by insiders?
    0 PHBBF shares are owned by insiders